Related Experiment Video
Updated: Apr 14, 2026

03:14
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
1.3K
Fully Automated Abstraction of Longitudinal Breast Oncology Records with Off-The-Shelf Large Language Models
James C Dickerson1, Marni B McClure1,2, Margaret Shaw1
1Stanford University, Stanford, CA, USA 94305.
Medrxiv : the Preprint Server for Health Sciences
|April 3, 2026
Summary
Large language models (LLMs) can now abstract complex oncology data from clinical notes, matching expert oncologist performance for key variables. This advances retrospective research by enabling scalable data extraction from medical records.
Area of Science:
- Oncology
- Medical Informatics
- Computational Biology
Background:
- Manual chart abstraction is a significant bottleneck in clinical research, particularly for oncology studies relying on narrative data.
- Key outcomes like disease recurrence and treatment history are often confined to clinical notes, limiting study scale and quality.
- Developing automated methods for data abstraction is crucial for advancing observational and epidemiologic oncology research.
Purpose of the Study:
- To assess the performance of large language models (LLMs) in abstracting diverse variables from complex, longitudinal oncology records.
- To determine if LLM-based abstraction can achieve performance comparable to expert medical oncologists.
- To evaluate the feasibility of using LLMs for creating research-grade retrospective datasets.
Main Methods:
- An open-source, HIPAA-compliant pipeline was developed using commercially available LLMs for data abstraction.
- Key variables including diagnosis/recurrence dates, clinical stage, biomarkers, and systemic therapies were extracted from unstructured clinical notes, pathology reports, and other records.
- A reference standard was created by expert breast oncologists abstracting the same variables; LLM performance was compared against this standard and inter-oncologist variability.
Main Results:
- The best-performing LLM achieved high concordance with expert oncologists for critical variables (e.g., 99% for recurrence status, 100% for BRCA1/2 variants, 96% for HER2 status).
- LLM performance for anti-cancer drug extraction approached inter-oncologist variability, outperforming research coordinators.
- Survival and hazard ratio estimates derived from LLM-abstracted data were similar to those from expert-derived datasets.
Conclusions:
- General-purpose LLMs, integrated into a fixed retrieval pipeline, can effectively abstract variables from complex oncology records with performance near expert levels.
- This approach eliminates the need for model fine-tuning or institution-specific retraining, offering a practical solution.
- The study demonstrates a viable method for scaling the creation of research-grade retrospective datasets from narrative medical records.
Related Concept Videos
Longitudinal Research
13.7K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.7K
Longitudinal Studies
692
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
692
Cancer Survival Analysis
846
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
846
